researching the key technologies of prevention, screening, diagnosis and treatment of Alzheimer's disease
HUNAN QANKOREY BIOTECHNOLOGY COMPANY LTD
It is a Sino-foreign joint venture focusing on the research of cutting-edge medical technology, a national high-tech enterprise, a governing unit of China Association for Alzheimer's Disease
FRONT-END SCIENCTIFIC RESEARCH TECENOLOGY
Qankorey cooperates with top Australian scientific research institutes Florey. Florey Institute of Neuroscience and Mental Health, Global Flagship Study of Alzheimer's Disease and Australian Imaging, Biomarker & Lifestyle Flagship Study of Aging (AIBL). We focus on global medical problems, researching the key technologies of prevention, screening, diagnosis and treatment of Alzheimer's disease.
DIVERSIFIED SOLUTIONS COVERING THE FULL-CYCLE OF AlZHEIER'S MANAGEMENT
QUALITATIVE SCREENING
QUANTITATIVE DIAGNOSIS
THERAPEUTIC DRUG
TECHNOLOGY WIZARD
The world's top neuroscientist
Australian scholar of "Future Thousand Talents Plan"
PhD Supervisor, Senior Research Fellow at the Florey Institute of Neuroscience and Mental Health
Head of the Natural Phagocytosis Laboratory, University of Melbourne
Visiting Professor, College of Medicine, University of Sydney
Visiting Professor, Xiangya Hospital Central South University
PI, National Clinical Research Center for Geriatric Diseases
The only international partner of the Ministry of Science and Technology in the major project of active health
Officially recognized A-Class talent
INTERNATIONAL TEAM
The founder of the innate phagocytosis theory, as a leader to establish a team of international high-level researchers, who devote themselves to researching Alzheimer's disease, innovating ideas, coming up with more methods, and overcoming difficulties, and have made brilliant achievements in diagnosis and treatment technologies against Alzheimer's disease.